Story
Funding Neuro are launching an appeal to bring one of the worlds most advanced immunotherapy trials for glioblastoma to Scotland. We are raising the £500,000 required to complete the trial. The trial will run at Ninewells Hospital in Dundee led by Dr Kismet Hossain-Ibrahim (FRCS (SN), PhD) Consultant Neurosurgeon. The trial will involve ten patients, whose own immune system will be used to target this deadly brain tumour. The trial will use a new vaccine targeting Cytomegalovirus (CMV) for Glioblastoma, which has been developed in the United States. This is an exciting opportunity to help translate this discovery from the lab into an effective treatment for patients. Glioblastoma, also known as glioblastoma multiforme (GBM), is the most aggressive cancer that begins within the brain. Initially, signs and symptoms of glioblastoma are non-specific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. Can you help those in need now?